On Tuesday, Plus Therapeutics Inc (NASDAQ: PSTV) was 6.35% up from the session before settling in for the closing price of $0.63. A 52-week range for PSTV has been $0.16 – $2.31.
Annual sales at Healthcare sector company grew by 46.51% over the past five years. When this article was written, the company’s average yearly earnings per share was at 87.69%. With a float of $136.95 million, this company’s outstanding shares have now reached $137.43 million.
Plus Therapeutics Inc (PSTV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Plus Therapeutics Inc stocks. The insider ownership of Plus Therapeutics Inc is 0.35%, while institutional ownership is 4.89%. The most recent insider transaction that took place on Nov 04 ’25, was worth 10,200. In this transaction Chief Financial Officer of this company bought 20,000 shares at a rate of $0.51, taking the stock ownership to the 68,138 shares. Before that another transaction happened on Aug 22 ’25, when Company’s Director bought 110,000 for $0.49, making the entire transaction worth $53,779. This insider now owns 139,327 shares in total.
Plus Therapeutics Inc (PSTV) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.49 earnings per share (EPS) during the time that was better than consensus figure (set at -0.5) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.04% during the next five years compared to 46.51% growth over the previous five years of trading.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
You can see what Plus Therapeutics Inc (PSTV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.90, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Plus Therapeutics Inc (NASDAQ: PSTV) saw its 5-day average volume 6.37 million, a negative change from its year-to-date volume of 18.61 million. As of the previous 9 days, the stock’s Stochastic %D was 68.91%.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 53.64%, which indicates a significant decrease from 87.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0506 in the past 14 days, which was lower than the 0.0689 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6069, while its 200-day Moving Average is $0.5916. Nevertheless, the first resistance level for the watch stands at $0.7003 in the near term. At $0.7307, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7663. If the price goes on to break the first support level at $0.6343, it is likely to go to the next support level at $0.5987. The third support level lies at $0.5683 if the price breaches the second support level.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
There are 137,429K outstanding shares of the company, which has a market capitalization of 92.08 million. As of now, sales total 5,820 K while income totals -12,980 K. Its latest quarter income was 1,400 K while its last quarter net income were -4,420 K.
